Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1967 1
1968 1
1970 1
1974 1
1975 1
1976 1
1978 1
1979 1
1980 1
1981 2
1982 1
1983 2
1984 1
1985 1
1986 3
1987 2
1988 2
1989 1
1990 2
1991 7
1992 3
1993 5
1994 3
1995 2
1996 5
1997 9
1998 9
1999 12
2000 15
2001 12
2002 10
2003 16
2004 15
2005 21
2006 11
2007 16
2008 14
2009 18
2010 16
2011 34
2012 30
2013 29
2014 27
2015 35
2016 38
2017 21
2018 32
2019 36
2020 30
2021 26
2022 30
2023 28
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

585 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for angulo tu
Search for Anguo Tu instead (1 results)
Tackling Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer.
Blaquier JB, Ortiz-Cuaran S, Ricciuti B, Mezquita L, Cardona AF, Recondo G. Blaquier JB, et al. Clin Cancer Res. 2023 Sep 15;29(18):3579-3591. doi: 10.1158/1078-0432.CCR-22-1912. Clin Cancer Res. 2023. PMID: 37093192 Review.
The comprehension and access to tissue and cell-free DNA next-generation sequencing have fueled the development of innovative therapeutic strategies to prevent and overcome resistance to osimertinib in the clinical setting. Herein, we review the biological and clinical imp …
The comprehension and access to tissue and cell-free DNA next-generation sequencing have fueled the development of innovative therapeutic …
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, Lopez-Gitlitz A, Trudel GC, Espina BM, Shu Y, Park YC, Rackoff WR, Yu MK, Small EJ; SPARTAN Investigators. Smith MR, et al. N Engl J Med. 2018 Apr 12;378(15):1408-1418. doi: 10.1056/NEJMoa1715546. Epub 2018 Feb 8. N Engl J Med. 2018. PMID: 29420164 Free article. Clinical Trial.
Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial.
Miller JL, Gevers E, Bridges N, Yanovski JA, Salehi P, Obrynba KS, Felner EI, Bird LM, Shoemaker AH, Angulo M, Butler MG, Stevenson D, Abuzzahab J, Barrett T, Lah M, Littlejohn E, Mathew V, Cowen NM, Bhatnagar A; DESTINY PWS Investigators. Miller JL, et al. J Clin Endocrinol Metab. 2023 Jun 16;108(7):1676-1685. doi: 10.1210/clinem/dgad014. J Clin Endocrinol Metab. 2023. PMID: 36639249 Free PMC article. Clinical Trial.
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study.
Chamorro DF, Cardona AF, Rodríguez J, Ruiz-Patiño A, Arrieta O, Moreno-Pérez DA, Rojas L, Zatarain-Barrón ZL, Ardila DV, Viola L, Recondo G, Blaquier JB, Martín C, Raez L, Samtani S, Ordóñez-Reyes C, Garcia-Robledo JE, Corrales L, Sotelo C, Ricaurte L, Cuello M, Mejía S, Jaller E, Vargas C, Carranza H, Otero J, Archila P, Bermudez M, Gamez T, Russo A, Malapelle U, de Miguel Perez D, de Lima VCC, Freitas H, Saldahna E, Rolfo C, Rosell R; CLICaP. Chamorro DF, et al. Target Oncol. 2023 May;18(3):425-440. doi: 10.1007/s11523-023-00955-9. Epub 2023 Apr 5. Target Oncol. 2023. PMID: 37017806 Free PMC article.
Gonococcal arthritis.
Angulo JM, Espinoza LR. Angulo JM, et al. Compr Ther. 1999 Mar;25(3):155-62. doi: 10.1007/BF02889612. Compr Ther. 1999. PMID: 10200905 Review.
Diabetes and ageing-induced vascular inflammation.
Assar ME, Angulo J, Rodríguez-Mañas L. Assar ME, et al. J Physiol. 2016 Apr 15;594(8):2125-46. doi: 10.1113/JP270841. Epub 2015 Nov 2. J Physiol. 2016. PMID: 26435167 Free PMC article. Review.
Further research is needed to determine the specific inflammatory mechanisms responsible for exacerbated vascular impairment in older diabetic subjects in order to design effective therapeutic interventions to minimize the impact of vascular inflammation. ...
Further research is needed to determine the specific inflammatory mechanisms responsible for exacerbated vascular impairment in older diabet …
Antivenoms for snakebite envenomings.
Gutiérrez JM, León G, Lomonte B, Angulo Y. Gutiérrez JM, et al. Inflamm Allergy Drug Targets. 2011 Oct;10(5):369-80. doi: 10.2174/187152811797200669. Inflamm Allergy Drug Targets. 2011. PMID: 21745181 Review.
Cetirizine-induce cholestasis.
Fong DG, Angulo P, Burgart LJ, Lindor KD. Fong DG, et al. J Clin Gastroenterol. 2000 Oct;31(3):250-3. doi: 10.1097/00004836-200010000-00016. J Clin Gastroenterol. 2000. PMID: 11034010
585 results